⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for recurrent oropharyngeal cancer

Every month we try and update this database with for recurrent oropharyngeal cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Low Antioxidant Diet in Controlling Cachexia in Patients With Oropharyngeal Cancer Receiving Chemotherapy and Radiation TherapyNCT00486304
Cachexia
Head and Neck C...
Weight Changes
ADD
Placebo
18 Years - UNC Lineberger Comprehensive Cancer Center
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced and/or Recurrent Head and Neck CancerNCT00004097
Head and Neck C...
fluorouracil
gemcitabine hyd...
paclitaxel
radiation thera...
18 Years - National Cancer Institute (NCI)
Surgery, Radiation Therapy, and Combination Chemotherapy in Treating Patients With Recurrent Head and Neck CancerNCT00003777
Head and Neck C...
amifostine trih...
cisplatin
fluorouracil
surgical proced...
radiation thera...
18 Years - 120 YearsAbramson Cancer Center at Penn Medicine
EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue SarcomaNCT00004261
Breast Cancer
Cervical Cancer
Head and Neck C...
Prostate Cancer
Sarcoma
EF5
flow cytometry
fluorescent ant...
immunohistochem...
biopsy
18 Years - 120 YearsUniversity Health Network, Toronto
Amifostine Plus Chemotherapy and Radiation Therapy in Treating Patients With Advanced, Unresectable Head and Neck CancerNCT00003251
Drug/Agent Toxi...
Head and Neck C...
Radiation Toxic...
amifostine trih...
cisplatin
paclitaxel
radiation thera...
18 Years - National Cancer Institute (NCI)
Paclitaxel in Treating Patients With Recurrent or Refractory Head and Neck CancerNCT00003327
Head and Neck C...
paclitaxel
18 Years - National Cancer Institute (NCI)
L-778,123 in Treating Patients With Recurrent or Refractory Solid TumorsNCT00003430
Head and Neck C...
Unspecified Adu...
L-778,123
18 Years - Memorial Sloan Kettering Cancer Center
Sargramostim in Decreasing Mucositis in Patients Receiving Radiation Therapy for Head and Neck CancerNCT00008398
Head and Neck C...
Oral Complicati...
Radiation Toxic...
sargramostim
quality-of-life...
radiation thera...
- Radiation Therapy Oncology Group
18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis TherapyNCT01806675
Adult Giant Cel...
Adult Glioblast...
Adult Gliosarco...
Male Breast Can...
Metastatic Squa...
Recurrent Adeno...
Recurrent Adult...
Recurrent Basal...
Recurrent Colon...
Recurrent Esthe...
Recurrent Hypop...
Recurrent Inver...
Recurrent Laryn...
Recurrent Lip a...
Recurrent Lymph...
Recurrent Lymph...
Recurrent Metas...
Recurrent Midli...
Recurrent Mucoe...
Recurrent Nasop...
Recurrent Non-s...
Recurrent Oroph...
Recurrent Pancr...
Recurrent Paran...
Recurrent Recta...
Recurrent Renal...
Recurrent Saliv...
Stage IIIA Brea...
Stage IIIA Non-...
Stage IIIB Brea...
Stage IIIB Non-...
Stage IIIC Brea...
Stage IV Breast...
Stage IV Non-sm...
Stage IV Pancre...
Stage IV Renal ...
Stage IVA Colon...
Stage IVA Recta...
Stage IVA Saliv...
Stage IVB Colon...
Stage IVB Saliv...
Stage IVC Saliv...
Tongue Cancer
Unspecified Adu...
18F-fludeoxyglu...
18F-FPPRGD2
18 Years - Stanford University
EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue SarcomaNCT00004261
Breast Cancer
Cervical Cancer
Head and Neck C...
Prostate Cancer
Sarcoma
EF5
flow cytometry
fluorescent ant...
immunohistochem...
biopsy
18 Years - 120 YearsUniversity Health Network, Toronto
L-778,123 in Treating Patients With Recurrent or Refractory Solid TumorsNCT00003430
Head and Neck C...
Unspecified Adu...
L-778,123
18 Years - Memorial Sloan Kettering Cancer Center
Cisplatin and Gemcitabine in Treating Patients With Advanced Squamous Cell Cancer of the Head and NeckNCT00003182
Head and Neck C...
cisplatin
gemcitabine hyd...
18 Years - National Cancer Institute (NCI)
Low Antioxidant Diet in Controlling Cachexia in Patients With Oropharyngeal Cancer Receiving Chemotherapy and Radiation TherapyNCT00486304
Cachexia
Head and Neck C...
Weight Changes
ADD
Placebo
18 Years - UNC Lineberger Comprehensive Cancer Center
Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Refractory Solid TumorsNCT00499291
Cancer
paclitaxel albu...
gene expression...
laboratory biom...
pharmacological...
polymerase chai...
18 Years - 120 YearsEastern Cooperative Oncology Group
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: